About NomosLogic
A Mission Born from Necessity
NomosLogic was built because the infrastructure for truly individualized medicine does not yet exist.
For too long, healthcare has relied on population averages: average risks, average responses, average treatment pathways. That model has produced important advances, but it has also left something essential behind the individual person standing in front of the clinician.
NomosLogic exists to help close that gap.
We are building clinical decision support infrastructure for a future in which care is more individualized, more explainable, and more biologically grounded. A future in which genomics is not treated as a novelty or an isolated test, but as part of the operational fabric of care.
The Story Behind the Company
Matt Hardy
Founder & CEO, NomosLogic Inc., Salt Lake City, Utah
NomosLogic did not begin as a business idea. It began as a personal reckoning.
For years, I lived with symptoms that never fully resolved into a coherent explanation: fatigue, brain fog, chronic pain, gastrointestinal issues, metabolic dysfunction, and a long history of fragmented care. Like many people, I moved through a system built in silos, with different specialists, different tests, different prescriptions, but no unifying view of the whole person.
Then I ran my own laboratory data alongside a consumer DNA file that had been sitting unused for years.
What came back changed everything.
It revealed clinically meaningful pharmacogenomic risk, actionable safety findings, and interacting genomic factors that helped explain patterns standard care had never connected. Not theoretical signals. Not vague predispositions. Real findings with real implications for treatment and safety.
That moment became the foundation for NomosLogic.
It made one fact impossible to ignore: some of the most important signals in healthcare are already present, but the systems needed to interpret, connect, and act on them in a clinically meaningful way are still missing.
Patient MH-001
This company began with my own case.
In my own genome, I found clinically significant risks that had never been surfaced through standard care. I found pharmacogenomic findings that could have had serious consequences if the wrong medications had been prescribed. I found interacting genomic architecture tied to gastrointestinal risk, iron dysregulation, metabolic vulnerability, and medication response.
Most importantly, I found that none of it had been meaningfully integrated into care.
It should not take building your own platform to discover what matters in your own genome.
That is why NomosLogic exists.
Not because my story is unique, but because it is not. Too many people are still treated as though they are interchangeable with the average patient. Too many clinically relevant signals remain buried across records, reports, and raw genomic data with no usable infrastructure to bring them together.
Why We Built NomosLogic
To make clinically relevant complexity visible.
We are creating infrastructure that connects genomic information, clinical context, pharmacogenomics, laboratory data, and decision logic in a way that is fast, explainable, and operationally useful. Our goal is not to replace clinicians. It is to support clinician decision-making with better context, better pattern recognition, and better individualized insight.
We believe the future of medicine requires systems that are:
Individualized, not merely population-averaged
Explainable, not black-box
Workflow-aware, not detached from care reality
Clinically serious, not consumer-tech theater
Traceable and deterministic where safety matters
Built for real use, not just theoretical promise
Why I Built It
The intersection of biology and architecture.
My background sits at the intersection of biology, systems architecture, and long-horizon technical design.
I began in biology and pre-med before spending more than three decades building complex software and infrastructure systems. Over time, that combination led me to a clear conclusion: healthcare does not simply need more data. It needs better architecture.
Medicine is full of signals that remain disconnected, underused, or invisible at the point of care. NomosLogic was born from the conviction that these signals can be structured, interpreted, and made clinically useful in a way that supports better decisions for real people.
What we are building is not a thin application layer or a generic AI wrapper. It is clinical intelligence infrastructure designed to support individualized medicine in ways that are explainable, scalable, and grounded in biological reality.
The Books
Two foundational works behind NomosLogic.
Deterministic Convergence
Biological Systems, Architecture, and the Search for Hidden Order
Matthew Hardy
Biology does not work the way modern genomics reads it. For more than three decades, genomics has been organized around the assumption that disease, drug response, and trait expression can be explained by identifying the variants involved. The result has been an immense catalog of associations and a clinical reality in which the same variants often produce different outcomes in different people. Deterministic Convergence argues that gap is not incidental. It is structural.
The book introduces deterministic convergence and distributed constraint architecture, two operationalized concepts that reframe genomic interpretation from fragment-centered analysis to architecture-centered analysis. Across six clinical domains, cardiovascular, neurological, oncological, renal, metabolic, and hematological, biological systems repeatedly reveal structured behavior that prevailing methods can describe only in parts. A list of parts is not a description of the system that holds the parts together. Biology becomes more intelligible at the level of architecture.
Available on Amazon
The Adaptation Paradox
How Evolution’s Gifts Became Medicine’s Problems
Second Edition, Matt Hardy
The intellectual foundation behind NomosLogic. The Adaptation Paradox explores why many modern health conditions are not simple genetic defects but evolutionary adaptations mismatched to contemporary environments. Traits that once conferred survival advantages such as efficient fat storage, heightened immune responses, and altered metabolic pathways can become liabilities when the environment changes faster than biology can follow.
This framework directly informs how NomosLogic interprets genomic architecture: not as a catalog of risk variants, but as a record of evolutionary selection pressure that shapes drug response, disease susceptibility, and system resilience in ways that population-average medicine was never designed to see.
Available on AmazonWhat We Believe
Our work is guided by a few core beliefs.
The individual matters more than the average.
Population-scale research matters, but care happens one person at a time.
Genomics should function as infrastructure.
Genomic information should not sit idle in raw files or disconnected reports. It should be translated into clinically relevant insight that can support real decisions.
Clinical systems must remain explainable.
In healthcare, opacity is not sophistication. When the stakes are high, systems must be reviewable, traceable, and understandable.
Technology should strengthen human judgment.
NomosLogic is built to support clinicians, not displace them.
Many modern risks are adaptation mismatches, not simple defects.
Human biology carries the signatures of past adaptation. Understanding that changes both interpretation and intervention.
The Bigger Vision
Beyond one company and one founder’s story.
NomosLogic is about helping medicine move beyond fragmented, population-average care toward a model that is more individualized, more coherent, and more deeply aligned with how human biology actually works.
We believe that shift will require more than better messaging and more than more data. It will require better infrastructure, better standards, and a more disciplined way of thinking about clinical intelligence.
That is the work we are doing.
NomosLogic began with a simple but uncomfortable realization: some of the most clinically important information in a person’s life can already exist, and still remain unseen.
We are building so that it does not stay unseen.
- Matt Hardy
Founder & CEO, NomosLogic